Do Latest SURPASS Findings With Twincretin in Diabetes Impress?
SURPASS-5 is latest published trial of novel investigational once-weekly twincretin drug. Editorialist says it leaves a number of unanswered questions about how best to use tirzepatide, if approved.
Medscape Medical News
source https://www.medscape.com/viewarticle/968251?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/968251?src=rss
Comments
Post a Comment